fIPV (0.1 mL) ID — Competitive Intelligence Brief

fIPV (0.1 mL) ID (fIPV (0.1 mL) ID) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: vaccine. Area: Immunology.

marketed vaccine poliovirus types 1, 2, and 3 antigens Immunology Biologic

Target snapshot

fIPV (0.1 mL) ID (fIPV (0.1 mL) ID) — Centers for Disease Control and Prevention. fIPV is an inactivated polio vaccine that stimulates the immune system to produce antibodies against poliovirus types 1, 2, and 3.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
fIPV (0.1 mL) ID TARGET	fIPV (0.1 mL) ID	Centers for Disease Control and Prevention	marketed	vaccine	poliovirus types 1, 2, and 3 antigens
2wIPV+1sIPV	2wIPV+1sIPV	Sinovac Biotech Co., Ltd	marketed	Inactivated viral vaccine	Poliovirus types 1, 2, and 3 antigens
1wIPV+2sIPV	1wIPV+2sIPV	Sinovac Biotech Co., Ltd	marketed	Inactivated polio vaccine (IPV)	Poliovirus types 1, 2, and 3 antigens
Comirnaty	BNT162b2 (tozinameran)	Pfizer Inc.	marketed	vaccine	SARS-CoV-2 virus	2021-08-23
Prevnar 20	pneumococcal 20-valent conjugate vaccine (PCV20)	Pfizer Inc.	marketed	Pneumococcal conjugate vaccine	Streptococcus pneumoniae capsular polysaccharides (20 serotypes)	2021-06-08
Streptococcus pneumoniae serotype 3	Streptococcus pneumoniae serotype 3	University of Oxford	marketed	Pneumococcal conjugate vaccine	Streptococcus pneumoniae serotype 3 capsular polysaccharide
HBsAg	HBsAg	Vaxine Pty Ltd	marketed	Vaccine	Hepatitis B surface antigen (HBsAg)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

• 2033-06-01 — Prevnar 20 · US 8,895,024 · Composition of matter · US
• 2035-06-01 — Prevnar 20 · US 10,279,033 · Method of use · US

Sponsor landscape (vaccine class)

1. Pfizer · 20 drugs in this class
2. Sanofi Pasteur, a Sanofi Company · 20 drugs in this class
3. GlaxoSmithKline · 12 drugs in this class
4. Merck Sharp & Dohme LLC · 12 drugs in this class
5. Centers for Disease Control and Prevention · 9 drugs in this class
6. Zhejiang Provincial Center for Disease Control and Prevention · 7 drugs in this class
7. Jiangsu Province Centers for Disease Control and Prevention · 6 drugs in this class
8. Beijing Center for Disease Control and Prevention · 6 drugs in this class
9. International Centre for Diarrhoeal Disease Research, Bangladesh · 5 drugs in this class
10. Sinovac Biotech Co., Ltd · 4 drugs in this class